Cytokinetic effects of anthralin on psoriatic keratinocytes.
D000873:Anthracenes / Q000627:therapeutic use*; D000875:Anthralin / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D004817:Epidermis / Q000473:pathology*; D006801:Humans; D007633:Keratins; D011565:Psoriasis / Q000473:pathology*
D000873:Anthracenes; D007633:Keratins; D000875:Anthralin